APA

Beurel E., Kornprobst M., Blivet-Van Eggelpoël M., Ruiz-Ruiz C., Cadoret A., Capeau J. & Desbois-Mouthon C. (20041124). GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression. : Experimental cell research.

Chicago

Beurel Eléonore, Kornprobst Michel, Blivet-Van Eggelpoël Marie-José, Ruiz-Ruiz Carmen, Cadoret Axelle, Capeau Jacqueline and Desbois-Mouthon Christèle. 20041124. GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression. : Experimental cell research.

Harvard

Beurel E., Kornprobst M., Blivet-Van Eggelpoël M., Ruiz-Ruiz C., Cadoret A., Capeau J. and Desbois-Mouthon C. (20041124). GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression. : Experimental cell research.

MLA

Beurel Eléonore, Kornprobst Michel, Blivet-Van Eggelpoël Marie-José, Ruiz-Ruiz Carmen, Cadoret Axelle, Capeau Jacqueline and Desbois-Mouthon Christèle. GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression. : Experimental cell research. 20041124.